Invention Grant
- Patent Title: HSP90B N-terminal isoform-selective inhibitors
-
Application No.: US16477398Application Date: 2018-01-12
-
Publication No.: US10927076B2Publication Date: 2021-02-23
- Inventor: Brian S. J. Blagg , Caitlin Nicole Kent , Anuj Khandelwal , Sanket Jaiprakash Mishra
- Applicant: University of Kansas
- Applicant Address: US KS Lawrence
- Assignee: University of Kansas
- Current Assignee: University of Kansas
- Current Assignee Address: US KS Lawrence
- Agency: Foley & Lardner LLP
- International Application: PCT/US2018/013666 WO 20180112
- International Announcement: WO2018/132769 WO 20180719
- Main IPC: C07D209/44
- IPC: C07D209/44 ; C07D209/46 ; C07D403/06 ; C07D403/10 ; C07D413/06 ; C07D413/10 ; A61P35/04
Abstract:
The present technology provides compounds according to Formula (I) as well as compositions including such compounds useful for the treatment of cancers such as non-small cell lung cancer, bladder cancer, or colon cancer.
Public/Granted literature
- US20190337894A1 HSP90B N-TERMINAL ISOFORM-SELECTIVE INHIBITORS Public/Granted day:2019-11-07
Information query
